Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART])

被引：27

作者：

Daida, H

Kuwabara, Y

Yokoi, H

Nishikawa, H

Takatsu, F

Nakata, Y

Kutsumi, Y

Oshima, S

Nishiyama, S

Ishiwata, S

Kato, K

Nishimura, S

Miyauchi, K

Kanoh, T

Yamaguchi, H

机构：

[1] Juntendo Univ, Sch Med, Dept Cardiol, Bunkyo Ku, Tokyo 1138421, Japan

[2] Chiba Univ, Chiba, Japan

[3] Yamada Red Cross Hosp, Yamada, Japan

[4] Anjo Kosei Hosp, Anjo, Japan

[5] Juntendo Izu Nagaoka Hosp, Nagaoka, Niigata, Japan

[6] Fukui Med Sch Hosp, Fukui, Japan

[7] Gunma Cardiovasc Ctr, Maebashi, Gumma, Japan

[8] Toranomon Gen Hosp, Tokyo, Japan

[9] Yokohama Rosai Hosp, Yokohama, Kanagawa, Japan

[10] Juntendo Urayasu Hosp, Urayasu, Japan

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 86卷 / 05期

关键词：

D O I：

10.1016/S0002-9149(00)01013-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To address the issue of whether probucol reduces clinical events after percutaneous transluminal coronary angioplasty (PTCA), we surveyed clinical status at 1 year after PTCA of 101 patients who had entered the Probucol Restenosis Angioplasty Trial. Repeat angioplasty at index lesions were required in 5 patients in the probucol group and in 12 in the control group, suggesting that probucol administered beginning 4 weeks before PTCA reduces repeat revascularization rates for 1 year.

引用

页码：550 / +

页数：4

共 8 条

[1]

[Anonymous], 1983, Clinical trials

[2]

Cote G, 1998, CIRCULATION, V98, P512

[3]

Fry ETA, 1998, CURR OPIN CARDIOL, V13, P232

[4] GUIDELINES FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A REPORT OF THE AMERICAN-COLLEGE-OF-CARDIOLOGY AMERICAN-HEART-ASSOCIATION TASK-FORCE ON ASSESSMENT OF DIAGNOSTIC AND THERAPEUTIC CARDIOVASCULAR PROCEDURES (COMMITTEE ON PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) [J].

RYAN, TJ ;

BAUMAN, WB ;

KENNEDY, JW ;

KEREIAKES, DJ ;

KING, SB ;

MCCALLISTER, BD ;

SMITH, SC ;

ULLYOT, DJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (07) :2033-2054

[5] A COMPARISON OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].

SERRUYS, PW ;

DEJAEGERE, P ;

KIEMENEIJ, F ;

MACAYA, C ;

RUTSCH, W ;

HEYNDRICKX, G ;

EMANUELSSON, H ;

MARCO, J ;

LEGRAND, V ;

MATERNE, P ;

BELARDI, J ;

SIGWART, U ;

COLOMBO, A ;

GOY, JJ ;

VANDENHEUVEL, P ;

DELCAN, J ;

MOREL, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :489-495

[6] Probucol and multivitamins in the prevention of restenosis after coronary angioplasty [J].

Tardif, JC ;

Cote, G ;

Lesperance, J ;

Bourassa, M ;

Lambert, J ;

Doucet, S ;

Bilodeau, L ;

Nattel, S ;

deGuise, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :365-372

[7] Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty [J].

Watanabe, K ;

Sekiya, M ;

Ikeda, S ;

Miyagawa, M ;

Hashida, K .

AMERICAN HEART JOURNAL, 1996, 132 (01) :23-29

[8] Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: The Probucol Angioplasty Restenosis Trial [J].

Yokoi, H ;

Daida, H ;

Kuwabara, Y ;

Nishikawa, H ;

Takatsu, F ;

Tomihara, H ;

Nakata, Y ;

Kutsumi, Y ;

Ohshima, S ;

Nishiyama, S ;

Seki, A ;

Kato, K ;

Nishimura, S ;

Kanoh, T ;

Yamaguchi, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :855-862

← 1 →